Terns Pharmaceuticals Inc (NASDAQ: TERN) on Tuesday, soared 3.41% from the previous trading day, before settling in for the closing price of $6.15. Within the past 52 weeks, TERN’s price has moved between $4.32 and $11.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 4.60%. With a float of $62.16 million, this company’s outstanding shares have now reached $84.92 million.
Let’s determine the extent of company efficiency that accounts for 66 employees. In terms of profitability, gross margin is 47.35%, operating margin of -7562.78%, and the pretax margin is -6641.75%.
Terns Pharmaceuticals Inc (TERN) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The most recent insider transaction that took place on Sep 12 ’24, was worth 4,999,995. In this transaction Director of this company bought 476,190 shares at a rate of $10.50, taking the stock ownership to the 476,190 shares. Before that another transaction happened on Sep 10 ’24, when Company’s Chief Financial Officer sold 10,000 for $11.00, making the entire transaction worth $110,000. This insider now owns 91,940 shares in total.
Terns Pharmaceuticals Inc (TERN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 4.60% per share during the next fiscal year.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Terns Pharmaceuticals Inc (TERN) is currently performing well based on its current performance indicators. A quick ratio of 32.99 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.36 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Looking closely at Terns Pharmaceuticals Inc (NASDAQ: TERN), its last 5-days average volume was 1.93 million, which is a jump from its year-to-date volume of 1.3 million. As of the previous 9 days, the stock’s Stochastic %D was 79.76%. Additionally, its Average True Range was 0.43.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 15.15%, which indicates a significant decrease from 43.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.44% in the past 14 days, which was lower than the 76.04% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.17, while its 200-day Moving Average is $7.11. However, in the short run, Terns Pharmaceuticals Inc’s stock first resistance to watch stands at $6.56. Second resistance stands at $6.77. The third major resistance level sits at $6.95. If the price goes on to break the first support level at $6.17, it is likely to go to the next support level at $5.99. Now, if the price goes above the second support level, the third support stands at $5.78.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
Market capitalization of the company is 540.21 million based on 84,939K outstanding shares. Right now, sales total 0 K and income totals -90,210 K. The company made 0 K in profit during its latest quarter, and -21,950 K in sales during its previous quarter.
